The Target Study
If you’re living with CRPS pain affecting the lower body (such as the foot, ankle, knee, leg, or hip), you may be a candidate for DRG therapy – a new, non-drug approach to pain relief currently being offered at select pain treatment centers through the TARGET Clinical Study. DRG therapy is FDA-approved for the treatment of CRPS pain affecting the lower limbs, and this study will help gather additional information about this new therapy.
As a participant in the TARGET Study, you will be asked to visit your local study center 4 times over a 12-month period after receiving your DRG system. During these visits, your study doctor will ask about how you are feeling, check your DRG system, and have you complete a few questionnaires to document your experiences. You may also be reimbursed for your time and travel to attend these visits.
To find out if you qualify for the TARGET Clinical Study, please contact Dr. Jeff Rowe or Clinical Research Coordinator Lauren Ziegler at +1 (610) 337-3111 Ext. 162.